Bronchoesophageal fistula due to multidrug-resistant tuberculosis in a patient infected with human immunodeficiency virus. 1995

D S Asnis, and H P Saltzman, and J A Giron

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D001983 Bronchial Fistula An abnormal passage or communication between a bronchus and another part of the body. Bronchial Fistulas,Fistula, Bronchial,Fistulas, Bronchial
D004937 Esophageal Fistula Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA. Esophageal Fistulas,Fistula, Esophageal,Fistulas, Esophageal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D018088 Tuberculosis, Multidrug-Resistant Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS. Tuberculosis, Drug-Resistant,Tuberculosis, MDR,Tuberculosis, Multi-Drug Resistant,Drug-Resistant Tuberculosis,MDR Tuberculosis,Multi-Drug Resistant Tuberculosis,Multidrug-Resistant Tuberculosis,Tuberculosis, Drug Resistant,Tuberculosis, Multi Drug Resistant,Tuberculosis, Multidrug Resistant

Related Publications

D S Asnis, and H P Saltzman, and J A Giron
December 2014, World journal of gastrointestinal surgery,
D S Asnis, and H P Saltzman, and J A Giron
September 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D S Asnis, and H P Saltzman, and J A Giron
November 1998, Kekkaku : [Tuberculosis],
D S Asnis, and H P Saltzman, and J A Giron
January 2019, Case reports in infectious diseases,
D S Asnis, and H P Saltzman, and J A Giron
March 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D S Asnis, and H P Saltzman, and J A Giron
December 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D S Asnis, and H P Saltzman, and J A Giron
May 2004, Journal of the European Academy of Dermatology and Venereology : JEADV,
D S Asnis, and H P Saltzman, and J A Giron
February 1997, Endoscopy,
D S Asnis, and H P Saltzman, and J A Giron
April 1998, Revista clinica espanola,
D S Asnis, and H P Saltzman, and J A Giron
August 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!